CN, S., P, S., ED, S., S, B., D, F., M, K., . . . M, B. (2025). Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy. Urologic oncology, 43(11), 661.e9-661.e17. https://doi.org/10.1016/j.urolonc.2025.07.013
Chicago Style (17th ed.) CitationCN, Sternberg, et al. "Evaluating Surrogates for Overall Survival in the Adjuvant Treatment of Bladder Cancer with Chemotherapy." Urologic Oncology 43, no. 11 (2025): 661.e9-661.e17. https://doi.org/10.1016/j.urolonc.2025.07.013.
MLA (9th ed.) CitationCN, Sternberg, et al. "Evaluating Surrogates for Overall Survival in the Adjuvant Treatment of Bladder Cancer with Chemotherapy." Urologic Oncology, vol. 43, no. 11, 2025, pp. 661.e9-661.e17, https://doi.org/10.1016/j.urolonc.2025.07.013.